Evidence map›Paper›PMID 35942160›Full record

ArticleClinical and translational discovery2022

Earlier detection of SARS-CoV-2 infection by blood RNA signature microfluidics assay.

Antonio Cappuccio, Jennifer Geis, Yongchao Ge, Venugopalan D Nair, Naveen Ramalingam, Weiguang Mao, Maria Chikina, Andrew G Letizia, Stuart C Sealfon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antonio CappuccioDepartment of Neurology Icahn School of Medicine at Mount Sinai New York New York USA.ORCID https://orcid.org/0000-0002-8266-2344
Jennifer GeisFluidigm Corporation San Francisco California USA.
Yongchao GeDepartment of Neurology Icahn School of Medicine at Mount Sinai New York New York USA.
Venugopalan D NairDepartment of Neurology Icahn School of Medicine at Mount Sinai New York New York USA.
Naveen RamalingamFluidigm Corporation San Francisco California USA.
Weiguang MaoDepartment of Computational and Systems Biology School of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA.
Maria ChikinaDepartment of Computational and Systems Biology School of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA.
Andrew G LetiziaNaval Medical Research Center Silver Spring Maryland USA.
Stuart C SealfonDepartment of Neurology Icahn School of Medicine at Mount Sinai New York New York USA.ORCID https://orcid.org/0000-0001-5791-1217

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID‐19host response assayinfection diagnosis

Identifiers

PMID35942160
PMCPMC9349572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.